AU2016199A - Peptide mimics useful for treating disease - Google Patents

Peptide mimics useful for treating disease

Info

Publication number
AU2016199A
AU2016199A AU20161/99A AU2016199A AU2016199A AU 2016199 A AU2016199 A AU 2016199A AU 20161/99 A AU20161/99 A AU 20161/99A AU 2016199 A AU2016199 A AU 2016199A AU 2016199 A AU2016199 A AU 2016199A
Authority
AU
Australia
Prior art keywords
treating disease
peptide mimics
mimics useful
useful
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20161/99A
Inventor
Soldano Ferrone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Medical College
Original Assignee
New York Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Medical College filed Critical New York Medical College
Publication of AU2016199A publication Critical patent/AU2016199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU20161/99A 1998-12-24 1998-12-24 Peptide mimics useful for treating disease Abandoned AU2016199A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/027633 WO2000038515A1 (en) 1998-12-24 1998-12-24 Peptide mimics useful for treating disease

Publications (1)

Publication Number Publication Date
AU2016199A true AU2016199A (en) 2000-07-31

Family

ID=22268554

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20161/99A Abandoned AU2016199A (en) 1998-12-24 1998-12-24 Peptide mimics useful for treating disease

Country Status (5)

Country Link
EP (1) EP1161147A4 (en)
JP (1) JP2002533357A (en)
AU (1) AU2016199A (en)
CA (1) CA2334958A1 (en)
WO (1) WO2000038515A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8024100A (en) * 1999-10-13 2001-04-23 Roswell Park Memorial Institute Induction of a strong immune response to a self-tumor associated antigen
DE50111493D1 (en) * 2001-09-03 2007-01-04 Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh Antigen mimotope and vaccine against cancer
WO2003074003A2 (en) * 2002-03-01 2003-09-12 Applied Immune Technologies Immunogens for treatment of neoplastic and infectious disease
US6998237B1 (en) * 2002-07-11 2006-02-14 Health Research, Inc. GD3 peptide mimics
EP2334701A4 (en) 2008-10-16 2014-01-08 Univ Pittsburgh Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229159A (en) * 1988-05-17 1992-11-25 Soldano Ferrone Anti-idiotype antibodies which bind to the idiotype of murine antibody 225.28
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
DE69533295T3 (en) * 1994-02-16 2009-07-16 The Government Of The United States Of America, As Represented By The Secretary, The Department Of Health And Human Services Melanoma-associated antigens, epitopes thereof and melanoma-containing vaccines
WO1997034613A1 (en) * 1996-03-19 1997-09-25 University Of Virginia Patent Foundation Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor

Also Published As

Publication number Publication date
EP1161147A1 (en) 2001-12-12
JP2002533357A (en) 2002-10-08
CA2334958A1 (en) 2000-07-06
WO2000038515A1 (en) 2000-07-06
EP1161147A4 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
AU2434199A (en) Protein
AU4989399A (en) Bone morphogenic protein
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
EP1018551A4 (en) Megsin protein
AU2071799A (en) Placental protein 13
AU2016199A (en) Peptide mimics useful for treating disease
PL344979A1 (en) Angiostatin-binding protein
GB9715064D0 (en) Protein expression
AUPO957397A0 (en) Transporter protein
AU6275098A (en) Novel h-rev 107-like protein
GB9828880D0 (en) Protein
GB9720784D0 (en) Protein
GB9519865D0 (en) Protein
AU2101799A (en) Human vps35/mem3-related protein
AU4992099A (en) Human presenilin-associated protein
AU2593199A (en) Human smn-like protein
AU9318798A (en) Ras-like protein
AU4438599A (en) Human arf-related proteins
AUPP460498A0 (en) Modified proteins
GB9809566D0 (en) Protein
GB9812607D0 (en) Protein
GB9819038D0 (en) Protein
AU6040598A (en) Blnk proteins
AU2658099A (en) Caf1-related protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase